(GRTX) – Hot Corp. News
-
Galera Therapeutics (GRTX) says FDA reiterated need for additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM
-
Galera Therapeutics (GRTX) Announces 70% Workforce Cut, CCO Departure
-
-
-
Back to GRTX Stock Lookup